MDR1 C3435T Polymorphism Indicates a Different Outcome in Advanced Multiple Myeloma

被引：10

作者：

Buda, Gabriele ^{[1
]}

Martino, Alessandro ^{[2
]}

Maggini, Valentina ^{[2
]}

Orciuolo, Enrico ^{[1
]}

Galimberti, Sara ^{[1
]}

Gentile, Massimo ^{[3
]}

Morabito, Fortunato ^{[3
]}

Antognoni, Federica ^{[4
]}

Brunori, Marino ^{[4
]}

Barale, Roberto ^{[2
]}

Rossi, Anna Maria ^{[2
]}

Petrini, Mario ^{[1
]}

机构：

[1] Univ Pisa, Sect Hematol, Dept Oncol Transplants & Adv Technol, IT-56100 Pisa, Italy

[2] Univ Pisa, Dept Biol, IT-56100 Pisa, Italy

[3] Azienda Osped, Hematol Unit, Cosenza, Italy

[4] Osped S Croce, Div Internal Med, Fano, Italy

来源：

ACTA HAEMATOLOGICA | 2009年 / 122卷 / 01期

关键词：

P-GLYCOPROTEIN; BORTEZOMIB; RESISTANCE; CYTOKINES;

D O I：

10.1159/000235820

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：42 / 45

页数：4

共 17 条

[1] MDR1 polymorphism influences the outcome of multiple myeloma patients [J].

Buda, Gabriele ;

Maggini, Valentina ;

Galimberti, Sara ;

Martino, Alessandro ;

Giuliani, Nicola ;

Morabito, Fortunato ;

Genestreti, Giovenzio ;

Iacopino, Pasquale ;

Rizzoli, Vittorio ;

Barale, Roberto ;

Rossi, Anna M. ;

Petrini, Mario .

BRITISH JOURNAL OF HAEMATOLOGY, 2007, 137 (05) :454-456

[2] ABCB1 (MDR1) rs1045642 is associated with increased overall survival in plasma cell myeloma [J].

Drain, Stephen ;

Catherwood, Mark A. ;

Orr, Nick ;

Galligan, Leeona ;

Rea, I. Maeve ;

Hodkinson, Clare ;

Drake, Mary B. ;

Kettle, Paul J. ;

Morris, T. C. M. 'Curly' ;

Alexander, H. Denis .

LEUKEMIA & LYMPHOMA, 2009, 50 (04) :566-570

[3] The role of tumor necrosis factor α in the pathophysiology of human multiple myeloma:: therapeutic applications [J].

Hideshima, T ;

Chauhan, D ;

Schlossman, R ;

Richardson, P ;

Anderson, KC .

ONCOGENE, 2001, 20 (33) :4519-4527

[4] Management of relapsed and relapsed refractory myeloma [J].

Kastritis, Efstathios ;

Mitsiades, Constantine S. ;

Dimopoulos, Meletios A. ;

Richardson, Paul G. .

HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2007, 21 (06) :1175-+

[5] Proteasome inhibition to maximize the apoptotic potential of cytokine therapy for murine neuroblastoma tumors [J].

Khan, Tahira ;

Stauffer, Jimmy K. ;

Williams, Rebecca ;

Hixon, Julie A. ;

Salcedo, Rosalba ;

Lincoln, Erin ;

Back, Timothy C. ;

Powell, Douglas ;

Lockett, Stephen ;

Arnold, Alma C. ;

Sayers, Thomas J. ;

Wigginton, Jon M. .

JOURNAL OF IMMUNOLOGY, 2006, 176 (10) :6302-6312

[6] Interleukin-6 and the network of several cytokines in multiple myeloma: An overview of clinical and experimental data [J].

Lauta, VM .

CYTOKINE, 2001, 16 (03) :79-86

[7] MDR1 diplotypes as prognostic markers in multiple myeloma [J].

Maggini, Valentina ;

Buda, Gabriele ;

Martino, Alessandro ;

Presciuttini, Silvano ;

Galimberti, Sara ;

Orciuolo, Enrico ;

Barale, Roberto ;

Petrini, Mario ;

Rossi, Anna Maria .

PHARMACOGENETICS AND GENOMICS, 2008, 18 (05) :383-389

[8] Genuine functions of P-glycoprotein (ABCB1) [J].

Mizutani, Takaharu ;

Masuda, Masatoshi ;

Nakai, Emi ;

Furumiya, Kenji ;

Togawa, Hiroshi ;

Nakamura, Yutaka ;

Kawai, Yuko ;

Nakahira, Keiko ;

Shinkai, Shigeko ;

Takahashi, Kazuhiko .

CURRENT DRUG METABOLISM, 2008, 9 (02) :167-174

[9]

Nakamura T, 2007, INT J ONCOL, V31, P803

[10] Involvement of C3435T and G2677T multidrug resistance gene polymorphisms in release of cytokines from peripheral blood mononuclear cells treated with methotrexate and dexamethasone [J].

Pawlik, A ;

Baskiewicz-Masiuk, M ;

Machalinski, B ;

Kurzawski, M ;

Gawronska-Szklarz, B .

EUROPEAN JOURNAL OF PHARMACOLOGY, 2005, 528 (1-3) :27-36

← 1 2 →